These preliminary findings urge further research into IDO2 expression and activity in brain tissue of PASC patients, into the presence of specific kynurenine metabolites and mitochondrial functioning of cells, and long-term effects into the functioning of various brain regions. The gene discussed is IDO2; the disease is long COVID-19.